Comparison of clinical features and health manifestations in lean vs. obese Indian women with polycystic ovarian syndrome

Journal of Human Reproductive Sciences

Volumn 2, Issue 1, 2009, Pages 12-17

  Majumdar, Abha ^a   Singh, Tejshree A ^a,b  

^a SIR GANGA RAM HOSPITAL   (India)

^b 28/76 West Patel Nagar ^*  (India)

Author keywords

Android obesity; Anovulation; Body mass index; Diabetes; Endometrial hyperplasia; Hyperandrogenism; Hypertension; Impaired glucose tolerance; Polycystic ovarian syndrome

Indexed keywords

ADULT; ARTICLE; BODY MASS; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; ENDOMETRIUM HYPERPLASIA; FEMALE; HEALTH HAZARD; HUMAN; HYPERANDROGENISM; HYPERTENSION; INDIAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; OBESITY; OVARY POLYCYSTIC DISEASE; PREVALENCE; PROSPECTIVE STUDY; TERTIARY HEALTH CARE;

EID: 77953473863     PISSN: 09741208     EISSN: 19984766     Source Type: Journal    
DOI: 10.4103/0974-1208.51336     Document Type: Article

References (32)

1. E Medicine Article on PCOS by Kathy Silvermann and Elizabeth M Aldermann. Available from: http://www emedicine. Com /linkus/htm. modification by Robert J Ferry Jr, MD, , University of Tennessee Health Science Center at Memphis and St Jude Children's Research Hospital; Updated: [last retrieved on 2008 Jul 10].
2. Bonnar J, Dunlop W, editors. Recent advances in obstretics and gynecology Vol 23. London: Royal Society of Medicine Press Limited; 2005.
3. Choo V. WHO reassesses appropriate body-mass index for Asian populations. The Lancet 2002;360:235.
4. G. Sotoudeh, SR Mirdamadi, F Siassi, S Khosravi and M Chamari. Relationships of overweight and obesity with hormonal and metabolic parameters in hirsute women. Acta medica iranica 2003;41:37-44.
5. Mayo Clinic Staff (2008). "High blood pressure (hypertension): Tests and diagnosis". Mayoclinic.com. [last retrieved on 2008 Sep 11].
6. Report of Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 26:S5-S20, 2003 by the American Diabetes Association, Inc.
7. Snehalatha C, Ramchandran A, Kapur A, Vijay V. Age-specific prevalence and risk associations for impaired glucose tolerance in urban southern Indian population. J Assoc Physicians India 2003;51:766-9.
8. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999;84:165-9.
9. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22:141-6.
10. Norman RJ, Masters L, Milner CR, Wang JX, Davies MJ. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod 2001;16:1995-8.
11. th Annual Meeting of The Endocrine Society, June 1995, Washington, D.C. Abstract#OR3-5, p.50.
12. Gambineri A, Pelusi C, Manicardi E, Vicennati V, Cacciari M, Morselli- Labate AM, et al.Glucose Intolerance in a Large Cohort of Mediterranean Women with Polycystic Ovary Syndrome. Diabetes 2004;53:2353-8.
13. Ciampelli M, Fulghesu AM, Cucinelli F, Pavone V, Ronsisvalle E, Guido M, Caruso A, Lanzone A. Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome. Metabolism 1999;48:167-72.
14. Ciampelli M, Fulghesu AM, Lanzone A. Comment on "Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome." J Clin Endocrinol Metab 1999;84:2974-5.
15. Glueck CJ, Wang P, Kobayashi S, Phillips H, Sieve-Smith L. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002;77:520-5.
16. Singhi M, Prabhakaran D, Goenka S, Jeemon P, Chaturvedi V, Reddy KS. Adverse risk profile for cardiovascular diseases in Asian Indian women. Presentation made at Forum 9, Mumbai, India, 12-16 September 2005.
17. Holte J, Gennarelli G, Berne C, Bergh T, Lithell H. Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: A sign of a pre-hypertensive state? Hum Reprod 1996;11:23-28.
18. Elting MW, Korsen TJ, Bezemer PD, Schoemaker J. Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population. Hum Reprod 2001;16:556-60.
19. Zimmermann S, Phillips RA, Dunaif A, Finegood DT, Wilkenfeld C, Ardeljan M, Gorlin R, Krakoff LR. Polycystic ovary syndrome: Lack of hypertension despite profound insulin resistance. J Clin Endocrinol Metab 1992;75:508-13.
20. Sampson M, Kong C, Patel A, Unwin R, Jacobs HS. Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome. Clin Endocrinol (Oxf) 1996;45:623-9.
21. Velazquez EM, Mendoza SG, Wang P, Glueck CJ. Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome. Metabolism 1997;46:454-7.
22. Kelly CJ, Speirs A, Gould GW, Petrie JR, Lyall H, Connell JM. Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:742-6.
23. Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK, Baron AD. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 2001;103:1410-5.
24. ICMR Task force project on Collaborative study of coronary Heart Study.
25. Singh RB, Beegom R, Mehta AS, Niaz MA, De AK, Haque M, et al. Prevalence and risk factors of hypertension and age-specific blood pressures in five cities: A study of Indian women. NKP Salve Institute of Medical Sciences, Nagpur, India. Five City Study Group. Int J Cardiol 1998;63:165-73.
26. Birdsall MA, Farquhar CM, White HD. Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann Intern Med 1997;126:32-5.
27. Talbott EO, Guzick DS, Sutton-Tyrrell K, McHugh-Pemu K P, Zborowski J V, Remsberg KE, Kuller LH. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 2000;20:2414-21.
28. nd, Fitzpatrick LA. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:2562-8.
29. Anthony P. Cheung Ultrasound and Menstrual History in Predicting Endometrial Hyperplasia in Polycystic Ovary Syndrome Obstetrics and Gynecology. The American College of Obstetricians and Gynecologists. 2001;98:325-31.
30. Tingthanatikul Y, Choktanasiri W, Rochanawutanon M, Weerakeit S. Prevalence and clinical predictors of endometrial hyperplasia in anovulatory women presenting with amenorrhea. Gynecol Endocrinol 2006;22:101-5.
31. Cheung A P. Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome. Obstet Gynecol 2001;98: 325-31.
32. Coulam CB, Annegers J F, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983;61:403-7.